analyst

NASDAQ · AXGN
AxoGen, Inc.
Healthcare · Medical - Devices
$49.37
Down-$0.26 (-0.52%)
Updated Nov 1, 2026, 6:05 AM
SID Score
6.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.38B
- P/E ratio
- -656.51
- Dividend yield
- 0.00%
- 52-week range
- $27.54 – $52.91
- Volume
- 1.84M
- Avg. volume
- 1.09M
Price performance · AXGN
AXGN price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
AXGN closed at $49.37 after 20 trading sessions, up 32.64% for the selected period.
- Last close
- $49.37
- Period change
- +32.64%
- Period low
- $34.62
- Period high
- $49.63
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $49.70 | $49.88 | $48.08 | $49.37 | 1.84M |
| Oct 29, 2026 | $49.61 | $51.16 | $48.39 | $49.63 | 2.28M |
| Oct 28, 2026 | $45.445 | $49.9699 | $43.50 | $49.25 | 9.29M |
| Oct 27, 2026 | $38.14 | $39.035 | $37.23 | $37.46 | 2.46M |
| Oct 26, 2026 | $38.06 | $38.71 | $37.71 | $38.02 | 1.02M |
| Oct 23, 2026 | $36.64 | $38.33 | $36.603 | $38.06 | 2.19M |
| Oct 22, 2026 | $36.48 | $37.29 | $36.21 | $36.68 | 961.63K |
| Oct 21, 2026 | $36.01 | $37.47 | $36.00 | $36.48 | 1.13M |
| Oct 20, 2026 | $35.71 | $36.84 | $35.5601 | $36.17 | 974.62K |
| Oct 19, 2026 | $34.86 | $35.26 | $34.11 | $35.24 | 782.54K |
| Oct 16, 2026 | $35.63 | $35.65 | $34.40 | $34.62 | 1.14M |
| Oct 15, 2026 | $35.14 | $36.42 | $35.14 | $35.63 | 986K |
| Oct 14, 2026 | $35.91 | $36.55 | $35.03 | $35.14 | 1.17M |
| Oct 13, 2026 | $37.20 | $37.40 | $35.83 | $36.17 | 2.14M |
| Oct 12, 2026 | $36.80 | $37.305 | $35.72 | $37.11 | 1.61M |
| Oct 9, 2026 | $36.35 | $36.80 | $35.60 | $36.13 | 929.75K |
| Oct 8, 2026 | $35.98 | $36.32 | $35.44 | $36.18 | 1.38M |
| Oct 7, 2026 | $36.31 | $36.88 | $35.825 | $36.04 | 1.6M |
| Oct 6, 2026 | $37.23 | $37.61 | $35.82 | $36.31 | 2.35M |
| Oct 5, 2026 | $37.47 | $38.27 | $36.79 | $37.22 | 2.19M |
Latest AXGN news
The latest Smart Investors Daily articles mentioning AXGN.
Stock researchResearch & News · News
Company
Market Activity
Research & News
Loading stock research…

